In This Article:
In the last week, the market has been flat, but it is up 33% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying stocks with strong potential can be particularly rewarding for investors looking to capitalize on growth opportunities.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Morris State Bancshares | 10.20% | -0.28% | 6.97% | ★★★★★★ |
Mission Bancorp | 25.37% | 16.23% | 20.16% | ★★★★★★ |
Teekay | NA | -6.48% | 55.79% | ★★★★★★ |
Omega Flex | NA | 1.31% | 3.88% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.12% | 10.04% | ★★★★★★ |
First National Bank Alaska | 221.06% | 2.98% | 1.82% | ★★★★★☆ |
Banco Latinoamericano de Comercio Exterior S. A | 311.64% | 21.07% | 24.77% | ★★★★★☆ |
Valhi | 38.71% | 2.57% | -19.76% | ★★★★★☆ |
QDM International | 36.42% | 107.08% | 78.76% | ★★★★★☆ |
FRMO | 0.17% | 12.99% | 23.62% | ★★★★☆☆ |
Here's a peek at a few of the choices from the screener.
SBC Medical Group Holdings
Simply Wall St Value Rating: ★★★★★☆
Overview: SBC Medical Group Holdings Incorporated offers management services to cosmetic treatment centers in Japan, Vietnam, and internationally, with a market cap of $968.14 million.
Operations: SBC Medical Group Holdings generates revenue primarily from its healthcare facilities and services segment, which amounted to $217.54 million.
SBC Medical Group Holdings, a small cap healthcare player, has shown impressive growth with earnings up 164% over the past year, outpacing the industry’s 8%. Despite shareholders experiencing substantial dilution recently, SBC trades at a significant discount of 92.9% below estimated fair value. The company was added to the NASDAQ Composite Index on September 20, 2024. With high-quality earnings and more cash than total debt, SBC's financial health appears robust.
-
Click to explore a detailed breakdown of our findings in SBC Medical Group Holdings' health report.
-
Understand SBC Medical Group Holdings' track record by examining our Past report.
Valhi
Simply Wall St Value Rating: ★★★★★☆
Overview: Valhi, Inc. operates in the chemicals, component products, and real estate management and development sectors across Europe, North America, the Asia Pacific, and internationally with a market cap of $953.53 million.
Operations: Valhi, Inc. generates revenue primarily from its chemicals segment ($1.78 billion), followed by component products ($157.40 million) and real estate management and development ($78.50 million). The company's net profit margin is a key metric to evaluate its profitability across these diverse revenue streams.